Xylem Q1 2024 Adj EPS $0.90 Beats $0.84 Estimate, Sales $2.033B Beat $1.997B Estimate
Portfolio Pulse from Benzinga Newsdesk
Xylem (NYSE:XYL) reported Q1 2024 adjusted EPS of $0.90, surpassing the $0.84 estimate, and sales of $2.033B, exceeding the $1.997B estimate. This represents a 13.92% increase in earnings and a 40.40% increase in sales from the same period last year.
May 02, 2024 | 11:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Xylem's Q1 2024 earnings and sales beat estimates, with a 13.92% increase in EPS and a 40.40% increase in sales year-over-year.
Xylem's better-than-expected Q1 2024 earnings and sales figures indicate strong financial health and operational efficiency, likely leading to positive investor sentiment and a potential increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100